JP2025513664A5 - - Google Patents

Info

Publication number
JP2025513664A5
JP2025513664A5 JP2024505118A JP2024505118A JP2025513664A5 JP 2025513664 A5 JP2025513664 A5 JP 2025513664A5 JP 2024505118 A JP2024505118 A JP 2024505118A JP 2024505118 A JP2024505118 A JP 2024505118A JP 2025513664 A5 JP2025513664 A5 JP 2025513664A5
Authority
JP
Japan
Prior art keywords
substituted
amino acid
alkyl
conjugate according
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024505118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513664A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038904 external-priority patent/WO2023009835A2/en
Publication of JP2025513664A publication Critical patent/JP2025513664A/ja
Publication of JP2025513664A5 publication Critical patent/JP2025513664A5/ja
Pending legal-status Critical Current

Links

JP2024505118A 2022-03-23 2022-10-28 ムチン-1に特異的な抗体コンジュゲート及びその使用方法 Pending JP2025513664A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263322914P 2022-03-23 2022-03-23
US63/322,914 2022-03-23
US202263344932P 2022-05-23 2022-05-23
US63/344,932 2022-05-23
PCT/US2022/038904 WO2023009835A2 (en) 2021-07-30 2022-10-28 Antibody conjugates specific for mucin-1 and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2025513664A JP2025513664A (ja) 2025-04-30
JP2025513664A5 true JP2025513664A5 (enExample) 2025-11-06

Family

ID=89834545

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024505118A Pending JP2025513664A (ja) 2022-03-23 2022-10-28 ムチン-1に特異的な抗体コンジュゲート及びその使用方法

Country Status (6)

Country Link
US (1) US20250152724A1 (enExample)
JP (1) JP2025513664A (enExample)
KR (1) KR20250160368A (enExample)
CN (1) CN120282965A (enExample)
AU (1) AU2022317537A1 (enExample)
CA (1) CA3227975A1 (enExample)

Similar Documents

Publication Publication Date Title
JP7403507B2 (ja) 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート
JP2024096335A (ja) 親水性抗体-薬物コンジュゲート
DK2678037T3 (en) Branched linker for protein pharmaceutical conjugates
SA516371381B1 (ar) مواد اقتران عقار جسم مضاد (adcs) مع بروتين مغزل كينسين (ksp)
AU2020234394A1 (en) Site-specific antibody conjugation and antibody-drug conjugate as specific example thereof
JP2022530524A5 (enExample)
TW201620554A (zh) 抗her2抗體-藥物結合物
RU2007116973A (ru) Терапевтические средства с пониженной токсичностью
JP2022547434A (ja) 標的化デンドリマー複合体
JP2025508009A5 (enExample)
CN112601522A (zh) 抗体-alk5抑制剂偶联物及其用途
JP2008515889A5 (enExample)
JP2024545170A5 (enExample)
WO2024227439A1 (zh) 具有靶向作用的偶联物及其制备方法和用途
CN115052663A (zh) Alk5抑制剂缀合物及其用途
JP2024529466A5 (enExample)
JP2025508779A5 (enExample)
CN119156232A (zh) 抗体-药物偶联物前体及其合成中间体
JP2025513664A5 (enExample)
CN114269388A (zh) 抗体-alk5抑制剂缀合物及其用途
JP2024529506A5 (enExample)
CN120225226A (zh) B7-h3抗体药物偶联物及其应用
EP4659764A1 (en) Linker drug, and preparation method and use of antibody-drug conjugate thereof
JP2024532677A5 (enExample)
CN119816522B (zh) 5t4抗体药物偶联物及其应用